| Asthma |
1 |
1 |
| Severe Asthma |
0 |
0.75 |
| Biologic Therapy |
0 |
0.59 |
| Allergy |
0 |
0.53 |
| Steroids |
0 |
0.47 |
| Corticosteroids |
0 |
0.26 |
| Insurance |
0 |
0.26 |
| Pandemic |
0 |
0.26 |
| Immunoglobulin E (IgE) |
0 |
0.23 |
| Inhaled Corticosteroid |
0 |
0.22 |
| Immunoglobulin E (IgE) Antibody |
0 |
0.2 |
| Inhalers |
0 |
0.16 |
| Lung |
0 |
0.16 |
| Primary Care |
0 |
0.16 |
| Pulmonary Function Test |
0 |
0.16 |
| Washington DC |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.13 |
| Intensive Care Unit |
0 |
0.12 |
| Complete Blood Count |
0 |
0.11 |
| Otolaryngology |
0 |
0.11 |
| Adherence |
0 |
0.1 |
| Adverse Effects |
0 |
0.1 |
| Anaphylaxis |
0 |
0.1 |
| Blood |
0 |
0.1 |
| Financial Reimbursement |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Hospitalists |
0 |
0.1 |
| Office Visits |
0 |
0.1 |
| Quality of Life |
0 |
0.1 |
| Referral |
0 |
0.1 |
| Washington |
0 |
0.1 |
| COVID-19 |
0 |
0.06 |
| Erectile Dysfunction |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Bone |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Ear |
0 |
0.05 |
| Eosinophils |
0 |
0.05 |
| Hyperglycemia |
0 |
0.05 |
| Immunoglobulin A (IgA) |
0 |
0.05 |
| Interleukin |
0 |
0.05 |
| Mouth |
0 |
0.05 |
| Nitric Oxide |
0 |
0.05 |
| Nose |
0 |
0.05 |
| Pollutant |
0 |
0.05 |
| Salary and Compensation |
0 |
0.05 |
| Telehealth and Telemedicine |
0 |
0.05 |
| Travel Medicine |
0 |
0.05 |
| Weight Gain |
0 |
0.05 |
| Patient Safety |
0 |
0.04 |
| Hypertension |
0 |
0.03 |
| Fractures |
0 |
0.02 |
| Toxicology |
0 |
0.01 |
| Weight Management |
0 |
0.01 |